Overview

Effect of Hyaluronidase in Different Doses Added to Bupivacaine on TAB Block Quality During CS

Status:
NOT_YET_RECRUITING
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
evaluate the efficacy of hyaluronidase in different doses as an adjuvant to bupivacaine in ultrasound-guided TAB block during CS
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Benha University
Treatments:
Hyaluronoglucosaminidase